This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Rainer Fuchs: Innovator in Gene Expression Analysis
Introduction
Rainer Fuchs is a notable inventor based in Sudbury, MA (US). He has made significant contributions to the field of gene expression analysis through his innovative methodologies. His work focuses on providing highly accurate and reproducible methods for quantifying differential gene expression.
Latest Patents
Rainer Fuchs holds a patent for a mathematical analysis methodology aimed at estimating changes in the level of gene expression. The patent, titled "Mathematical analysis for the estimation of changes in the level of gene expression," presents a mathematically-based approach that circumvents the limitations of previous heuristic methodologies. This invention utilizes a Bayesian framework to derive mathematical formulas that determine the a posteriori distribution of fold-changes in gene expression. The methodology offers estimators for fold-change levels, confidence limits, and P-values for assessing statistical significance.
Career Highlights
Rainer Fuchs is associated with Aventis Pharmaceuticals Inc., where he applies his expertise in mathematical analysis to advance research in gene expression. His innovative work has the potential to enhance the accuracy of gene expression quantification, which is crucial for various applications in biotechnology and medicine.
Collaborations
Rainer has collaborated with notable colleagues such as Joachim Theilhaber and Steven Bushnell. These collaborations have likely contributed to the development and refinement of his innovative methodologies.
Conclusion
Rainer Fuchs is a distinguished inventor whose work in mathematical analysis for gene expression has paved the way for more accurate and reliable methodologies in the field. His contributions continue to impact research and development in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile